Trials / Completed
CompletedNCT00398151
To Evaluate the Inflammatory Markers in Adult Patients With Asthma Associated With Allergic Rhinitis Receiving Montelukast Therapy (0476-366)
An Open-Label Study to Evaluate the Inflammatory Markers in Adult Patients With Asthma Associated With Allergic Rhinitis Receiving Montelukast Therapy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 58 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the changes in proinflammatory markers (ltd4 in urine) and eosinophil from peripheral blood after newly initiated montelukast therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0476, montelukast sodium / Duration of Treatment: 12 Weeks |
Timeline
- Start date
- 2005-08-01
- Primary completion
- 2006-01-18
- Completion
- 2006-01-18
- First posted
- 2006-11-10
- Last updated
- 2024-08-15
Source: ClinicalTrials.gov record NCT00398151. Inclusion in this directory is not an endorsement.